WA People
BILL · 2019–20 SESSION · LATEST VERSION SHB 1352

HB 1352: Drug compounding

Compounding drugs.

Summary

  • Changes requirements regarding the compounding of drugs by a licensed pharmacist.

From the House Bill Report (HB 1352), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 21, 2019
  2. Out of committeeFeb 19, 2019
  3. Passed Housestopped here
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
My-Linh Thai (D-41)
Introduced
January 21, 2019 in the House
Last action
January 13, 2020
Companion bill
SB 5663
Budget
Has a fiscal note
Versions
HB 1352, SHB 1352

AN ACT Relating to drug compounding;

Sponsors

Prime sponsor: My-Linh Thai (D-41)

5 co-sponsors (4 Democrats, 1 Republican)

Paul Harris R-17Vandana Slatter D-48Sherry Appleton D-23Laurie Jinkins D-27Lillian Ortiz-Self D-21

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Referred to Health Care & Wellness. (SHB 1352)
  2. By resolution, reintroduced and retained in present status. (SHB 1352)
  3. Rules Committee relieved of further consideration. (SHB 1352)
  4. Referred to Health Care & Wellness.
  5. Rules Committee relieved of further consideration.
  6. By resolution, reintroduced and retained in present status.
  7. Referred to Rules 2 Review. (SHB 1352)
  8. Referred to Rules 2 Review.
  9. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 1352)
  10. HCW - Majority; 1st substitute bill be substituted, do pass.
  11. First reading, referred to Health Care & Wellness.

HB 1352 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page